1,054 results on '"Smith, Eric L."'
Search Results
2. Use of an Antibiotic-Impregnated Spacer in Revision Total Knee Arthroplasty
3. Beyond BCMA: newer immune targets in myeloma
4. Socioeconomic Disadvantage Predicts Decreased Likelihood of Maintaining a Functional Knee Arthroplasty Following Treatment for Prosthetic Joint Infection
5. The Relative Importance of Factors That Applicants Weigh When Ranking Adult Reconstruction Fellowships as Well as Their Perspectives on Robotic-Assisted Arthroplasty
6. Product warranties by orthopaedic surgery companies. Quality control or a new fad?
7. Optimizing the manufacturing and antitumour response of CAR T therapy
8. Modular Knee Arthrodesis as Definitive Treatment for Periprosthetic Infection, Bone Loss, and Failure of the Extensor Mechanism After Total Knee Arthroplasty
9. Revision Total Knee Arthroplasty in an Outpatient Setting: A Growing Alternative
10. Antibiotic Prophylaxis Prior to Dental Procedures After Total Hip and Knee Arthroplasty Does Not Decrease the Risk of Periprosthetic Joint Infection
11. The Future of Chimeric Antigen Receptor T Cell Therapy
12. Arthroscopic Procedures Are Performed in 5% of Patients With Knee Osteoarthritis 1 Year Preceding Total Knee Arthroplasty and Are Associated With Increased Stiffness and Increased Costs
13. Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma
14. The Cost of Stiffness After Total Knee Arthroplasty
15. Intraosseous Regional Administration of Antibiotic Prophylaxis for Total Knee Arthroplasty: A Systematic Review
16. Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: a prospective observational cohort study
17. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma
18. A Safe Number of Perioperative Opioids to Reduce the Risk of New Persistent Usage Among Opioid-Naïve Patients Following Total Joint Arthroplasty
19. The Microbiome of Osteoarthritic Hip and Knee Joints: A Prospective Multicenter Investigation
20. Association Between Surgical Opioid Prescriptions and Opioid Initiation by Opioid-naïve Spouses
21. Reduced Narcotic Utilization in Total Joint Arthroplasty Patients in an Urban Tertiary Care Center
22. Drivers of Unequal Healthcare Costs in the Nonoperative Treatment of Late-Stage Knee Osteoarthritis Prior to Primary Total Knee Arthroplasty
23. The Cost-Effectiveness of Extended Oral Antibiotic Prophylaxis for Infection Prevention After Total Joint Arthroplasty in High-Risk Patients
24. Arthroplasty costs excluding implants: anatomic total shoulder versus reverse shoulder arthroplasty
25. Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma
26. Reducing Narcotic Usage With 0.5% Bupivacaine Periarticular Injections in Total Knee Arthroplasty
27. Total Knee Arthroplasty Hospital Costs by Time-Driven Activity-Based Costing: Robotic vs Conventional
28. Similar incidence of postoperative sciatic nerve palsy in direct anterior and posterior approach total hip arthroplasty.
29. No Association Between Intrauterine Contraceptive Devices and Musculoskeletal Hip Joint Pain
30. Financial Burden of Revision Hip and Knee Arthroplasty at an Orthopedic Specialty Hospital: Higher Costs and Unequal Reimbursements
31. The Cost of Hip and Knee Revision Arthroplasty by Diagnosis-Related Groups: Comparing Time-Driven Activity-Based Costing and Traditional Accounting
32. Out-of-Network Facility Charges for Patients Undergoing Outpatient Total Joint Arthroplasty
33. Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial
34. Costs of Nonoperative Procedures for Knee Osteoarthritis in the Year Prior to Primary Total Knee Arthroplasty
35. Hepatitis C Antiviral Treatment Decreases All-Cause Complications After Total Joint Arthroplasty Regardless of the Presence of Fibrosis
36. Reference Pricing Reduces Total Knee Implant Costs
37. Comparing the Risk of Osteonecrosis of the Femoral Head Following Intra-Articular Corticosteroid and Hyaluronic Acid Injections
38. Prognostic Factors for Postrelapse Survival after ex Vivo CD34+-Selected (T Cell-Depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma
39. The Obesity Paradox: Body Mass Index Complication Rates Vary by Gender and Age Among Primary Total Hip Arthroplasty Patients
40. Survivorship of Megaprostheses in Revision Hip and Knee Arthroplasty for Septic and Aseptic Indications: A Retrospective, Multicenter Study With Minimum 2-Year Follow-Up
41. Presalvage International Staging System Stage and Other Important Outcome Associations in CD34+-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma
42. Energy expenditure of femoral broaching in direct anterior total hip replacements—Comparison between manual and automated techniques
43. Product warranties by orthopaedic surgery companies. Quality control or a new fad?
44. Chronic Prescription Opioid Use Before and After Total Hip and Knee Arthroplasty in Patients Younger Than 65 Years
45. Early Discharge After Total Hip Arthroplasty at an Urban Tertiary Care Safety Net Hospital: A 2-Year Retrospective Cohort Study
46. Energy expenditure of femoral broaching in direct anterior total hip replacements—Comparison between manual and automated techniques.
47. The 22-Modifier in Reimbursement for Orthopedic Procedures: Hip Arthroplasty and Obesity Are Worth the Effort
48. CARs and other T cell therapies for MM: The clinical experience
49. Data from Activation of Tumor-Cell STING Primes NK-Cell Therapy
50. Data from BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.